31
CLCZ696B2319E1 OL Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF
Condition(s):Heart FailureLast Updated:September 18, 2020Recruiting
Valsartan: 405 Clinical Trials, Page 4 of 41
Hide Studies Not Open or Pending
32
Changes in NT-proBNP and Outcomes, Safety, and Tolerability in HFpEF Patients With Acute Decompensated Heart Failure (ADHF) Who Have Been Stabilized During Hospitalization and Initiated In-hospital or Within 30 Days Post-discharge (PARAGLIDE-HF)
Condition(s):Heart Failure With Preserved Ejection Fraction (HFpEF)Last Updated:September 17, 2020Recruiting
33
Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients
Condition(s):Heart Failure NYHA Class IV; Heart Failure NYHA Class IILast Updated:July 27, 2020Recruiting
34
The DDI Study of SP2086 and Valsartan
Condition(s):Type 2 DiabetesLast Updated:June 29, 2016Unknown status
35
Efficacy and Safety of Sacubitril/Valsartan in Maintenance Hemodialysis Patients With Heart Failure
Condition(s):Hemodialysis Complication; Heart FailureLast Updated:July 7, 2020Recruiting
36
The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients
Condition(s):Heart FailureLast Updated:August 5, 2020Recruiting
37
Sacubitril/Valsartan in Left Ventricular Assist Device Recipients
Condition(s):Heart FailureLast Updated:July 2, 2020Not yet recruiting
38
The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI
Condition(s):Heart FailureLast Updated:September 2, 2020Completed
39
Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension
Condition(s):Stage 2 Systolic HypertensionLast Updated:March 7, 2011Completed
40
Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
Condition(s):HypertensionLast Updated:July 1, 2010Completed